Are Analysts Bullish Cohen & Steers, Inc. (NYSE:CNS) After Last Week?

Cohen & Steers, Inc. (NYSE:CNS) Logo
Investors sentiment decreased to 1.12 in Q4 2018. Its down 0.18, from 1.3 in 2018Q3. It dived, as 14 investors sold Cohen & Steers, Inc. shares while 43 reduced holdings. 21 funds opened positions while 43 raised stakes. 20.48 million shares or 3.54% less from 21.23 million shares in 2018Q3 were reported.
Dupont Capital Mgmt Corp invested in 10,167 shares. 39,608 are held by Rhumbline Advisers. Raymond James And Assoc stated it has 47,877 shares or 0% of all its holdings. Oppenheimer Asset Mngmt holds 1,091 shares or 0% of its portfolio. State Board Of Administration Of Florida Retirement Systems, a Florida-based fund reported 19,614 shares. Bremer Trust National Association, Minnesota-based fund reported 87 shares. Credit Suisse Ag reported 11,528 shares or 0% of all its holdings. Miles Capital reported 18,019 shares or 0.61% of all its holdings. Ubs Asset Americas Inc owns 9,700 shares. Next Gru accumulated 0% or 23 shares. Jpmorgan Chase holds 0% or 81,980 shares. Captrust Advsrs stated it has 0% of its portfolio in Cohen & Steers, Inc. (NYSE:CNS). Wells Fargo & Commerce Mn holds 223,360 shares. Sageworth Tru accumulated 0.01% or 3,000 shares. Eagle Asset invested in 0.05% or 231,891 shares.

Cohen & Steers, Inc. (NYSE:CNS) Ratings Coverage

Among 2 analysts covering Cohen \u0026 Steers (NYSE:CNS), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Cohen \u0026 Steers had 4 analyst reports since January 25, 2019 according to SRatingsIntel. As per Wednesday, February 20, the company rating was downgraded by Keefe Bruyette & Woods. Wood upgraded Cohen & Steers, Inc. (NYSE:CNS) rating on Friday, January 25. Wood has “Market Perform” rating and $36 target. Below is a list of Cohen & Steers, Inc. (NYSE:CNS) latest ratings and price target changes.

22/04/2019 Broker: Gabelli Old Rating: Buy New Rating: Hold Downgrade
01/03/2019 Broker: BidaskScore Rating: Buy Upgrade
20/02/2019 Broker: Keefe Bruyette & Woods Rating: Sell New Target: $36 Downgrade
25/01/2019 Broker: Wood Old Rating: Underperform New Rating: Market Perform Old Target: $31 New Target: $36 Upgrade

The stock increased 1.31% or $0.65 during the last trading session, reaching $50.26. About 64,869 shares traded. Cohen & Steers, Inc. (NYSE:CNS) has risen 10.76% since May 8, 2018 and is uptrending. It has outperformed by 6.39% the S&P500.

Cohen & Steers, Inc. is a publicly owned asset management holding company. The company has market cap of $2.37 billion. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It has a 20.18 P/E ratio. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries.

More notable recent Cohen & Steers, Inc. (NYSE:CNS) news were published by: Benzinga.com which released: “Vistagen (NASDAQ:VTGN) Shares Fall Under $1 After Depression Drug Flunks Midstage Trial – Benzinga” on May 02, 2019, also Businesswire.com with their article: “Teva Announces Launch of a Generic Version of VESIcare® (solifenacin succinate) Tablets in the United States – Business Wire” published on April 22, 2019, Prnewswire.com published: “Biotech Brief: Optimism Rising for Cancer Treatment Advancements in 2019 – PRNewswire” on April 17, 2019. More interesting news about Cohen & Steers, Inc. (NYSE:CNS) were released by: Seekingalpha.com and their article: “4 Reasons To Avoid Cohen & Steers – Seeking Alpha” published on January 28, 2019 as well as Insurancenewsnet.com‘s news article titled: “Merck’s BELSOMRA® (suvorexant) C-IV Meets Primary Efficacy Endpoint in Phase 3 Trial for the Treatment of Insomnia in People with Mild-to-Moderate Alzheimer’s Disease Dementia – Insurance News Net” with publication date: May 07, 2019.

Cohen & Steers, Inc. (NYSE:CNS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.